SNY Sanofi American Depositary Shares (Each representing one-half of one ordinary share) Loading...

From TMO earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
08:30
Jan 29 ◎
Mark Casper Chairman, President, and CEO, Thermo Fisher Scientific Inc TMO Q4 FY25 call
Thermo Fisher acquires a sterile fill-finish plant from Sanofi, boosting its CDMO capacity; Sanofi monetizes a site while outsourcing fill-finish capacity.
SNY
HIGH
08:30
Oct 22 ◎
Mark Masper CEO, Thermo Fisher Scientific Inc TMO Q3 FY25 call
Thermo Fisher gains a new U.S. sterile fill-finish node with built-in Sanofi volume, supporting reshoring demand.
SNY
HIGH

About SNY Analyst Coverage

Buzzberg tracks SNY (Sanofi American Depositary Shares (Each representing one-half of one ordinary share)) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Mark Casper, Mark Masper.